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Background: Plasmodium vivax is one of the widespread human malarial parasites accounting for 75% of malaria
epidemics. However, there is no baseline information about the status and nature of genetic variation of Plasmodium
species circulating in various parts of Pakistan. The present study was aimed at observing the molecular epidemiology
and genetic variation of Plasmodium vivax by analysing its merozoite surface protein-3α (msp-3α) and merozoite surface
protein-3β (msp-3β) genes, by using suballele, species-specific, combined nested PCR/RFLP detection techniques.
Methods: A total of 230 blood samples from suspected subjects tested slide positive for vivax malaria were collected
from Punjab, Sindh, Khyber Pakhtunkhwa, and Balochistan during the period May 2012 to December 2013. Combined
nested PCR/RFLP technique was conducted using Pvmsp-3α and Pvmsp-3β genetic markers to detect extent of genetic
variation in clinical isolates of P. vivax in the studied areas of Pakistan.
Results: By PCR, P. vivax, 202/230 (87.82%), was found to be widely distributed in the studied areas. PCR/RFLP analysis
showed a high range of allelic variations for both msp-3α and msp-3β genetic markers of P. vivax, i.e., 21 alleles for
msp-3α and 19 for msp-3β. Statistically a significant difference (p≤ 0.05) was observed in the genetic diversity of the
suballelic variants of msp-3α and msp-3β genes of P. vivax.
Conclusion: It is concluded that P. vivax populations are highly polymorphic and diverse allelic variants of Pvmsp-3α
and Pvmsp-3β are present in Pakistan.
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Malaria is the major threat to public health and economic
development in many nations [1]. It kills more than a mil-
lion people a year, and approximately 40% of the world’s
populations live in malarious countries [2]. Plasmodium
vivax is the most widespread species of human malaria
parasites in the world and is endemic in many countries
of Asia, Central and South America, the Middle East, and
parts of Africa, with an estimated burden of 70-80 million
cases annually [3,4]. In Pakistan P. vivax is the common
malarial species, contributing to 70% of the malaria burden* Correspondence: shahid_kust@yahoo.com
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unless otherwise stated.[5]. Although P. vivax is highly prevalent, it has received
scant scientific attention in Pakistan, thus, a paucity of
baseline data exists on various aspects of P. vivax, such as
population structure and drug resistance patterns.
Genetic diversity is defined as the total number of
heritable characteristics in the genetic make-up of the
species [6]. Studies have shown that Plasmodium species
show diversity in several parameters, including morphology,
biochemistry, relapse patterns, symptoms, course and
duration of infection, immunological responses, drug
resistance, and transmissibility by anopheline vectors.
However, the extent of genetic diversity observed depends
on the transmission rates, immune pressure and natural
selection of the parasite in an area [7]. Usually in endemic
areas, where transmission rates are high, extensively di-
verse variants are in circulation, posing a threat to publicd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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creased virulence and resistance to drugs in order to fit
and survive [8].
Studies of the population structure of malaria parasites
are important for understanding the evolution of para-
site virulence and the role of parasite diversity in malaria
transmission, and for designing control tools, including
vaccines, as well as evaluating the impact of malaria con-
trol measures [9,10].
Pvmsp-3α and Pvmsp-3β have been used as markers in
population genetic studies worldwide [11-14]. The best
approach for detecting genetic diversity is to analyse
more than one marker gene, because by doing so the
probability of different clones sharing the same genotype
accidentally, is substantially reduced [15]. Accordingly, it
is suggested that analysis of both Pvmsp-3α and Pvmsp3β
genes of P. vivax enables greater ability in identifying
parasite haplotypes and detecting mixed strain infections
[11,12]. Limited data regarding the genetic diversity of
Pvmsp-3α and Pvmsp-3β is available from one endemic
area of Khyber Pakhtunkhwa province of Pakistan [16], it
is therefore, hypothesized that new allelic variants may be
present in other provinces of the country. This study will
seek to elaborate on the genetic polymorphism of P. vivax
malaria isolates and compare them with those reported
from other parts of the world.
Methods
Sample collection
This study was conducted with the approval of the Medical
Superintendents of source hospitals and the ethics com-
mittee of Kohat University of Science and Technology
(KUST) Kohat Pakistan. A total of 230 blood samples
were collected, after the informed consent from symp-
tomatic patients, with the assessment of malaria control
laboratories in the district headquarters hospitals of the
four provinces: Punjab, Sindh, Khyber Pakhtunkhwa,
and Balochistan during May 2012 to December 2013.
Out of these 230 samples, 58 were collected from Punjab,
54 from Sindh, 68 from Khyber Pakhtunkhwa, and 50
from Balochistan. All the samples were screened for the
detection of malarial parasites by microscope and PCR.
DNA purification
DNA of blood samples were extracted with the help of
DNA extraction kit (GF1, Vivantus, USA).
PCR amplification for Plasmodium vivax identification
The nested PCR amplification procedures used by Snounou
et al. and Singh et al. [17,18] were applied for amplification
and detection of the 18S rRNA type A gene size 1.2 Kb,
using species-specific primers rVIV1 5′-CGCTTCTAGC
TTAATCCACATAACTGATAC-3′ and rVIV2 5′-ACTTCCAAGCCGAAGCAAAGAAAGTCCTTA-3′ for the de-
tection of P. vivax.
PCR of Pvmsp-3α genes
By using PCR technique, the allelic variants of P. vivax
merozoite surface protein-3α were detected by standard
protocol of Bruce et al. [11]. Primary PCR of Pvmsp-3α
was performed in 20 ml using 3 ml of DNA, using
primers P1 (5′-CAGCAGACACCATTTAAGG-3′) and
P2 (5′-CCGTTTGTTGATTAGTTGC-3′), while nested
reactions were done in 20 μl with primers N1 (5′-GACC
AGTGTGATACCATTAACC-3′) and N2 (5′-ATACTG
GTTCTTCGTCTTCA GG-3′) using 3 μl of the primary
PCR product. Taq DNA polymerase (2.6 units) was used
and the following cyclic conditions were performed: 95°C
for 3 min, 94°C for 30 sec, 58°C for 30 sec, 68°C for
2.5 min (2, 30 times) and 72°C for 5 min. Two per cent
agarose gel was stained with ethidium bromide in order to
visualize the PCR separated product, under UV illumin-
ation. Gel documentation system (Clearver Scientific,
USA) was used for the photography.
RFLP analysis of Pvmsp-3α genes PCR products
For the RFLP analysis of Pvmsp-3α genes, Alu1 restriction
enzyme (Fermentas, USA) was used. The total volume of
the reaction medium was kept 20 μl having the following
reagents Alu1 buffer (1.2 μl), PCR water (9.8 μl), Alu1
enzyme (1.0 μl) and product of msp-3α gene (8.0 μl).
PCR of Pvmsp-3β genes
The allelic variants of P. vivax merozoite’s surface
protein-3 were detected by PCR analysis, using standard
protocol of Yang et al. [12]. For Pvmsp-3β, primary PCR
was performed in 20 μl using 3 μl of DNA using primers
P1 (5′-GTATTCTTCGCAACACTC-3′) and P2 (5′-CT
TCTGATGTTATTTCCAG-3′). Nested reactions were
done in 20 ml with primers N1 (5′-CGAGGGGCGAA
ATTGTAAACC-3′) and N2 (5′-GCTGCTTCTTTTGC
AAAGG-3′) using 1 μl of the primary PCR product as
the template. Taq DNA polymerase (2.6 units) (Vivantis,
USA) was used and the following cyclic conditions were
performed: 94°C for 20 sec, 54°C for 30 sec, 68°C for
2.5 min, 35 cycles. Agarose was used to visualize the
PCR product under UV illumination. Gel documentation
system (Clearver Scientific, USA) was used for the
photography.
RFLP analysis of Pvmsp-3β PCR products
The RFLP analysis of Pvmsp-3β gene was carried out, using
Pest 1 restriction enzyme (Fermentas, USA) described by
Yang et al. [12]. The total volume of the reaction medium
was kept as 20 μl. The master mix for RFLP analysis was
composed of Pest 1 Buffer 1.2 μl, PCR water 9.8 μl, Pest 1
enzyme 1.0 μl and product of msp-3β gene 8.0 μl.
Figure 1 Overall prevalence of vivax malaria in Pakistan
by PCR.
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The data were statistically analysed by using SPSS
(Version 20) with application of Kruskal Wallis test.
The p value less than 0.05 was assumed to be statistically
significant.
Results
Out of the total 230 samples, 202 samples were found
positive for P. vivax both by microscopy and PCR. The
distribution of the positive samples in the four prov-
inces of Pakistan remained: 58/68 (85.29%) for Khyber
Pakhtunkhwa, 53/58 (91.37%) for Punjab, 47/54 (87.03%)
for Sindh and 44/50 (88%) for Balochistan (Figure 1).
Analysis of pvmsp-3α gene by PCR /RFLP
A sum of 130/202 samples of blood were successfully
amplified for pvmsp-3α gene and were identified for
different genotypes of the aforementioned gene. ThreeFigure 2 PCR/RFLP analysis of P. vivax msp-3α gene. V shows P. vivax (
variants, while A, B, C and D with numbers indicate subtypes of the main a
pairs DNA marker.major allelic variants of different sizes, i.e., 2.2 kb (Type-A),
2.0 kb (Type-B), 1.1 kb (Type-C) were detected. Besides
these, an unusual band size of about 0.75 kb, named as
Type-D and mixed genotypes designated as M were also
observed (Figure 2). Out of the 130 amplified samples, the
frequency of the different types of alleles remained 64/130
(49.29%) for Type-A, 27/130 (20.76%) for Type-B, 27/130
(20.76%) for Type-C, 9/130 (6.92 %) for Type-D, and 3/130
(2.30 %) for mixed. Overall 12 suballelic variants (A1-A12)
for Type A, 5 (B1-B5) for Type B and 4 (C1-C4) for
Type-C were observed. The alleles A3, A9, B1, B2, and
C2 were frequently observed in all provinces of Pakistan
(Table 1).
Analysis of pvmsp-3β gene by PCR/RFLP
In the current study 72/202 samples of blood had been
successfully amplified for pvmsp-3β gene with a high
frequency of polymorphism among their different allelic
variants. The amplified DNA fragments for these alleles
were classified according to their size variation. Based
on variation in size of the fragments, the amplified sam-
ples could be differentiated into three allele sizes: for Type
A (2.0-2.5 kb), Type B (1.6-2.0 kb) and Type C (1.5 kb)
(Figure 3).
In all these amplified samples, a couple of samples
reflect more than one band of different sizes. These mul-
tiple bands show mixed infection, which revealed 2.77%
of the allelic variants. Out of the total 72 amplified
samples, 16 (22.22%) isolates for Type-A, 32 (44.44%)
for Type-B and 22 (30.55%) for Type-C were observed.
Among these isolates Type-B was found to have highest
per cent frequency and Type-A was found the lowest in
per cent frequency (Table 2).
In this study pvmsp-3β gene was analysed using Pst1
restriction enzyme and 7 suballelic variants, (A1-A7) forthe amplified product is 120 bp). A, B, C and D indicate the main allele
llele variants. M is a 50 base pairs DNA marker and m is a 1 kilo base
Table 1 Size, RFLP pattern and allelic frequency of Pvmsp-3α gene
Size variation RFLP by Alu1 Alleles Data analysis n (%) frequency distribution of sub-allelic variants
Punjab Sindh Khyber Pakhtunkhwa Balochistan Total
(n = 32) (n = 27) (n = 41) (n = 30) (n = 130)
A A1—A12 1 2 (6.25) 2 (7.40) 2 (4.87) 2 (6.66) 8 (6.15)
2 2 (6.25) 1 (3.70) 2 (4.87) 1 (3.33) 6 (4.61)
3 3 (9.37) 2 (7.40) 4 (9.75) 2 (6.66) 11 (8.46)
4 2 (6.25) 1 (3.70) 2 (4.87) 1 (3.33) 6 (4.61)
5 1 (3.12) 1 (3.70) 1 (2.43) 1 (3.33) 4 (3.07)
6 2 (6.25) 1 (3.70) 1 (2.43) 1 (3.33) 4 (3.07)
7 0 (0.00) 1 (3.70) 1 (2.43) 1 (3.33) 3 (2.30)
8 1 (3.12) 0 (0.00) 1 (2.43) 1 (3.33) 3 (2.30)
9 3 (9.37) 3 (11.11) 4 (9.75) 3 (10) 13 (10)
10 0 (0.00) 0 (0.00) 1 (2.43) 1 (3.33) 2 (1.53)
11 2 (6.25) 0 (0.00) 1 (2.43) 1 (3.33) 3 (2.30)
12 0 (0.00) 0 (0.00) 1 (2.43) 0 (0.00) 1 (0.76)
B B1—B5 13 3 (9.37) 3 (11.11) 3 (7.31) 2 (6.66) 11 (8.46)
14 2 (6.25) 3 (11.11) 3 (7.31) 3 (10) 11(8.46)
15 1 (3.12) 1 (3.70) 1 (2.43) 1 (3.33) 4 (3.07)
16 0 (0.00) 0 (0.00) 1 (2.43) 0 (0.00) 1 (0.76)
17 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00)
C C1—C4 18 2 (6.25) 1 (3.70) 2 (4.87) 1 (3.33) 6 (4.61)
19 4 (12.5) 3 (11.11) 4 (9.75) 4 (13.33) 15 (11.53)
20 2 (6.25) 1 (3.70) 2 (4.87) 1 (3.33) 6 (4.61)
21 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00)
D D1 22 2 (6.25) 2 (7.40) 3 (7.31) 2 (6.66) 9 (6.92)
M M1 23 0 (0.00) 1 (3.70) 1 (2.43) 1 (3.33) 3 (2.30)
Total frequency (%) 32 (24.61) 27 (20.76) 41 (31.53) 30 (23.07) 130 (64.35)
Mean ± SE 1.48 ± 0.80 1.30 ± 0.96 1.17 ± 0.92 1.78 ± 0.79
Kruskal wallis test p < 0.05
n = The number of subtypes of alleles that bear Alu1 RFLP pattern.
Figure 3 PCR/RFLP analysis of P. vivax msp-3β gene. A, B and C indicate the main allele variants, while A, B and C with numbers indicate
subtypes of the main allele variants. m is a 1 kilo base pairs DNA marker.
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Table 2 Size, RFLP pattern and allelic frequency of Pvmsp-3β gene
Size variation RFLP by Pst1 Alleles Data analysis n (%) frequency distribution of sub-allelic variants
Punjab Sindh Khyber Pakhtunkhwa Balochistan Total
(n = 21) (n = 20) (n = 17) (n = 14) (n = 72)
A A1—A7 A1 1(4.76) 1 (5) 0 (0.00) 1 (7.14) 3 (4.16)
A2 1(4.76) 1 (5) 0 (0.00) 0 (0.00) 2 (2.77)
A3 1(4.76) 1 (5) 1 (5.88) 0 (0.00) 3 (4.16)
A4 1(4.76) 2 (10) 1 (5.88) 1 (7.14) 5 (6.94)
A5 1(4.76) 0 (0.00) 1 (5.88) 0 (0.00) 2 (2.77)
A6 0 (0.00) 0 (0.00) 1 (5.88) 0 (0.00) 1 (1.38)
A7 - - - - -
B B1—B10 B1 1(4.76) 1 (5) 1 (5.88) 1 (7.14) 4 (5.55)
B2 2 (9.52) 2 (10) 2 (11.76) 2 (14.28) 8 (11.11)
B3 2 (9.52) 2 (10) 0 (0.00) 1 (7.14) 5 (6.94)
B4 1(4.76) 1 (5) 1 (5.88) 0 (0.00) 3 (4.16)
B5 1(4.76) 1 (5) 1 (5.88) 1 (7.14) 4 (5.55)
B6 2 (9.52) 3 (15) 2 (11.76) 0 (0.00) 7 (9.72)
B7 0 (0.00) 0 (0.00) 0 (0.00) 1 (7.14) 1 (1.38)
B8 - - - - -
B9 - - - - -
B10 - - - - -
C C1—C4 C1 2 (9.52) 2 (10) 2 (11.76) 1 (7.14) 7 (9.72)
C2 2 (9.52) 1 (5) 1 (5.88) 1 (7.14) 5 (6.94)
C3 1(4.76) 1 (5) 0 (0.00) 1 (7.14) 3 (4.16)
C4 2 (9.52) 1 (5) 1 (5.88) 1 (7.14) 5 (6.94)
C5 0 (0.00) 0 (0.00) 1 (5.88) 1 (7.14) 2 (2.77)
C6 - - - - -
M M1 M1 0 (0.00) 0 (0.00) 1 (5.88) 1 (7.14) 2 (2.77)
Total frequency (%) 21 (29.16) 20 (27.77) 17 (23.61) 14 (19.44) 72 (35.64)
Mean ± SE 1.11 ± 0.17 1.05 ± 0.19 0.89 ± 0.15 0.74 ± 0.13
Kruskal wallis test p < 0.05
n = The number of subtypes of alleles that bear Pst1 RFLP pattern.
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Type-C were observed. The suballeles B7-B10 were not
found in the present study (Table 2). The different
samples resolved through pst1 restriction enzyme, show a
high polymorphism in size and distribution among sam-
ples (Figure 3).
Discussion
Pakistan is endemic for malaria and there are reports
showing the distribution of various allelic variants of P.
vivax. So, this study was aimed with the main objectives
of identifying the new variants and to observe the epi-
demiology of level of pvmsp-3α and pvmsp-3β polymorph-
ism of P. vivax in Pakistan. In the current study four
distinct sizes of PCR products for Pvmsp-3α were de-
tected. Among these, three different major allelic variantsof different sizes, i.e., 2.2 kb (Type-A), 2.0 kb (Type-B),
1.1 kb (Type-C) along with unusual band size of almost
0.75 kb or 300 bp name as Type-D and mixed genotypes
designated as M, were observed in the study areas,
while in Thailand [13], Afghanistan [19] and the Federally
Administered Tribal Areas (FATA) of Pakistan [20],
only three allele sizes (A, B and C) were obtained for
this gene.
The frequency of the different types of alleles
remained 64/130 (49.29%) for Type-A, 27/130 (20.76%)
for Type-B, 27/130 (20.76%) for Type-C, 9/130 (6.92%)
for Type-D, and 3/130 (2.30%) for mixed, comparing
with the study of Khatoon et al. where 82% (41/50) iso-
lates having allele sizes 1.9 kb (Type-A), 6% (3/50) with
the 1.5 kb fragment (Type-B), 8% (4/50) with the
1.2 kb fragment (Type-C), 2% (1/50) with the 0.3 kb
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strain infection [16].
In this study restriction digestion of the Pvmsp-3α
PCR product with AluI yielded 12 suballelic variants
types: (A1-A12) for Type-A, 5 (B1-B5) for Type-B and 4
(C1-C4) for Type-C were observed. The alleles A3 11
(8.46%) and A9 13 (10%) for Type-A, allele B1 and B2
11 (8.46%) for Type-B and C2 15 (11.53%) for Type-C
were frequently observed in all provinces of Pakistan,
while in the similar study carried out by Khatoon et al.,
12 different alleles designated as A1-A7, B1, B2, C1, C2,
and D, allele A3 being the most abundant 12/50 (24%) [16].
The PCR-RFLP patterns for P. vivax Pvmsp-3β gene
produced three categories Type-A (2.0-2.5 kb), Type-B
(1.6-2.0 kb) and Type-C (1.5 kb). Similarly, in northwest
Thailand, three distinct allele types (A, B and C (~0.65 kb))
were found [12]. In contrast, studies carried out in dis-
trict Bannu by Khatoon et al. found two types of allele
A (1.7-2.2 kb) and B (1.4-1.5 kb) of size polymorphisms
for P. vivax Pvmsp-3β gene [16]. Compared with P. vivax
isolates from previous work conducted in Asia, the results
of the current study further confirmed the existence of
small geographic differentiation among P. vivax popula-
tions. An earlier study in western Thailand showed that
the B type of pvmsp-3β is more abundant (60.4%) than
other types, whereas in Chinese Bengbu and Guangxi
samples, both A and B types were similarly prevalent [12].
According to Zhong et al., the Type-A allele was the most
abundant in all four parasite populations (>57% more
abundant than other types), i.e., Anhui, Hainan, Yunnan,
and Myanmar [21]. In the current study, Type-B was
found to have the highest per cent frequency and Type-A
was found to have lowest per cent frequency.
Data from PCR-RFLP of the Pvmsp-3α and Pvmsp-3β
loci showed that 5.02% of the Pakistani P. vivax isolates
exhibited mixed-strain infections, which is comparable
to sites in Bengbu (China) (5.6%) and is lower than
observed in Thailand (20.5%) [12] and FATA of Pakistan
(30%), which directly shares a border with Afghanistan
[20]. In northern Iran [20] and Hongshuihe (China), no
mixed genotypes were detected [12]. Apart from differences
in transmission intensities in different areas, the observed
variations in parasite types could be attributed to factors
such as sampling bias, host immune selective pressure on
particular types and/or spatiotemporal changes in the
availability of different mosquito species that can transmit
specific parasite types in a particular area over different
times or seasons, with areas that share the same mosquito
types tending to have similar parasite types [20].
Conclusion
This study indicates that P.vivax populations in four
provinces of Pakistan: Punjab, Sindh, Khyber Pakhtunkhwa,
and Balochistan, are highly diverse. Such heterogeneitymight cause differences in parasite virulence, transmissi-
bility and responses to chemotherapy, with important im-
plications for malaria control measures in this populous
region.
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